Blockchain Registration Transaction Record

Lexaria Bioscience Receives Three New Patents, Grows Portfolio to 46 Granted Patents Worldwide

Lexaria Bioscience receives three new patents, expanding its portfolio to 46 granted patents worldwide. The company's DehydraTECH(TM) drug delivery platform technology offers increased bioavailability and effective oral delivery of APIs.

Lexaria Bioscience Receives Three New Patents, Grows Portfolio to 46 Granted Patents Worldwide

This news matters as it highlights the growing patent portfolio and the value of patents for biotechnology companies. It also emphasizes the potential competitive advantage and future commercial partnerships for Lexaria Bioscience.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x294df59db5846a237a848868868bc3a10ded9148d2b454f5b813ab5f3ade06be
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintvasteKYq-75d61b0007b12cb92d28d0b653de080e